[go: up one dir, main page]

JP7043136B2 - Dosing container nozzle and dosing container - Google Patents

Dosing container nozzle and dosing container Download PDF

Info

Publication number
JP7043136B2
JP7043136B2 JP2018099920A JP2018099920A JP7043136B2 JP 7043136 B2 JP7043136 B2 JP 7043136B2 JP 2018099920 A JP2018099920 A JP 2018099920A JP 2018099920 A JP2018099920 A JP 2018099920A JP 7043136 B2 JP7043136 B2 JP 7043136B2
Authority
JP
Japan
Prior art keywords
slide member
nozzle
base
container
dosing container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018099920A
Other languages
Japanese (ja)
Other versions
JP2019201996A (en
Inventor
功実 和田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2018099920A priority Critical patent/JP7043136B2/en
Publication of JP2019201996A publication Critical patent/JP2019201996A/en
Application granted granted Critical
Publication of JP7043136B2 publication Critical patent/JP7043136B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Bag Frames (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

本発明は、投薬容器用ノズル及び投薬容器に関する。 The present invention relates to a nozzle for a dosing container and a dosing container.

嚥下障害等により口から栄養が取れない患者の場合、経鼻胃管、胃瘻、腸瘻等の経管栄養補給法が行われている。このような経管栄養補給法では、ボトルやバッグ(以下、「投薬容器」という)に栄養剤を入れ、チューブを介して胃や腸に注入する。投薬容器には、排出部にノズルが設けられ、該ノズルにチューブが接続される。 For patients who cannot get nutrition from the mouth due to dysphagia or the like, tube feeding methods such as nasogastric tube, gastrostomy, and intestinal fistula are performed. In such a tube feeding method, a nutritional supplement is put in a bottle or a bag (hereinafter referred to as a “medication container”) and injected into the stomach or intestine via a tube. The dosing container is provided with a nozzle at the discharge portion, and a tube is connected to the nozzle.

近年、経腸栄養の分野では、相互接続防止コネクタとして、国際規格ISO(IEC)80369-3に規定されたねじ込み式のコネクタの適用が予定されている。 In recent years, in the field of enteral nutrition, the application of a screw-in type connector specified in the international standard ISO (IEC) 80369-3 is planned as an interconnection prevention connector.

従来、投薬容器用ノズルの構造として種々提案されている。例えば、特許文献1には、容器のノズルに隔壁が設けられ、先端に接続針が設けられたカテーテルをノズルにねじ込む過程で、接続針が隔壁を破断するカテーテル接続構造が記載されている。この構造では、雄コネクタに接続針を設ける必要があるため、前記ISO80369-3のコネクタには適用できない。 Conventionally, various proposals have been made as a structure of a nozzle for a dosing container. For example, Patent Document 1 describes a catheter connection structure in which a partition wall is provided on the nozzle of a container and the connecting needle breaks the partition wall in the process of screwing a catheter provided with a connecting needle at the tip into the nozzle. In this structure, since it is necessary to provide a connecting needle to the male connector, it cannot be applied to the ISO80369-3 connector.

また、特許文献2-4には、キャップのねじ込みによって容器の口部に設けたシール材を破断する技術が公知であるが、これを前記ISO80369-3のコネクタに適用するとしても、雄コネクタ又は雌コネクタに加工が必要であるため、投薬容器用ノズルには適用できない。 Further, Patent Document 2-4 knows a technique of breaking a sealing material provided at the mouth of a container by screwing a cap, but even if this is applied to the connector of ISO80369-3, a male connector or a male connector or Since the female connector needs to be processed, it cannot be applied to the nozzle for medication containers.

また、特許文献5には、投薬容器に収容部とノズルからなる排出部とを備え、収容部と排出部との境界部分を閉塞する閉塞部をさらに備え、収容部に医薬品と液体を収容して、医薬品を崩壊、懸濁させて、収容部に力を加えて閉塞部を開き、収容部内の医薬品と液体の混合物を排出部のノズルを経てチューブに流出することができる投薬容器が記載されている。この投薬容器の排出部には、前記ISO80369-3のコネクタを取り付けることは可能であるが、コネクタの接続と閉塞部の解放との2つの動作が必要であり、内容部物の補給動作が容易ではない。 Further, in Patent Document 5, the medication container is provided with a storage portion and a discharge portion including a nozzle, and further includes a closing portion for closing the boundary portion between the storage portion and the discharge portion, and the storage portion stores medicines and liquids. Described is a dosing container capable of disintegrating and suspending a drug, applying force to the containment to open the closure, and allowing a mixture of the drug and liquid in the containment to flow out into a tube through a nozzle in the discharge section. ing. Although it is possible to attach the ISO80369-3 connector to the discharge part of the dosing container, two operations of connecting the connector and releasing the closed part are required, and it is easy to replenish the contents. is not it.

特開2002-210023号公報Japanese Unexamined Patent Publication No. 2002-210023 特開2001-278322号公報Japanese Unexamined Patent Publication No. 2001-278322 特開平7-112749号公報Japanese Unexamined Patent Publication No. 7-112749 実用新案登録第2602651号明細書Utility Model Registration No. 2602651 特許第5873483号明細書Japanese Patent No. 5873483

本発明は、斯かる従来の問題点に鑑みてなされたもので、ISO80369-3のねじ込み式のコネクタを適用可能であり、容易に開くことができて、円滑に内容物を流出することができる投薬容器用ノズル及び投薬容器を提供することを課題とする。 The present invention has been made in view of such conventional problems, and an ISO 80369-3 screw-in type connector can be applied, can be easily opened, and the contents can be smoothly discharged. An object of the present invention is to provide a nozzle for a dosing container and a dosing container.

前記課題を解決するための手段として、本発明の投薬容器用ノズルは、
入口部と排出部とを有する投薬容器の前記排出部に取り付けられる投薬容器用ノズルにおいて、
前記投薬容器の内部と連通する貫通孔を有し、前記排出部に取り付けられる基部と、
前記基部に一体に形成され、前記基部の貫通孔に連通する円筒形状を有し、外周面に雄ねじが形成された雌コネクタとを備え、
前記投薬容器の内部と前記基部の前記貫通孔との間にシール部が設けられ、
前記シール部と前記雌コネクタとの間にスライド部材が設けられ、
前記雌コネクタに挿入される円筒部と、前記雄ねじに螺合する雌ねじが形成された外筒部とからなる雄コネクタが、前記雌コネクタに装着されると、前記スライド部材が移動して、前記シール部を解除するように構成されている。
As a means for solving the above-mentioned problems, the nozzle for a dosing container of the present invention is used.
In a nozzle for a medication container attached to the discharge portion of a medication container having an inlet portion and a discharge portion,
A base that has a through hole that communicates with the inside of the dosing container and is attached to the discharge portion.
It is provided with a female connector integrally formed with the base portion, having a cylindrical shape communicating with a through hole of the base portion, and having a male screw formed on the outer peripheral surface.
A seal is provided between the inside of the dosing container and the through hole at the base.
A slide member is provided between the seal portion and the female connector.
When a male connector including a cylindrical portion inserted into the female connector and an outer cylinder portion having a female screw screwed to the male screw is attached to the female connector, the slide member moves and the slide member moves. It is configured to release the seal.

シール部が閉じた状態で、投薬容器に医薬品と液体を収容し、雌コネクタに雄コネクタを装着すると、スライド部材が移動して、シール部が解除され、投薬容器内の医薬品と液体の混合物がスライド部材に沿って流出し、雌コネクタと雄コネクタを通り、チューブを介して、胃や腸に注入される。 When the medicine and liquid are stored in the medication container with the seal closed, and the male connector is attached to the female connector, the slide member moves, the seal is released, and the mixture of medicine and liquid in the medicine container is released. It drains along the slide member, passes through the female and male connectors, and is injected into the stomach and intestines via the tube.

前記スライド部材は、前記基部に接離可能な弁部を有し、
前記シール部は、前記弁部と前記基部の間に形成され、
前記スライド部材は、前記弁部を前記基部から離間して前記シール部を開放するように構成されている。
The slide member has a valve portion that can be attached to and detached from the base portion.
The seal portion is formed between the valve portion and the base portion, and is formed.
The slide member is configured to separate the valve portion from the base portion and open the seal portion.

前記シール部は、前記スライド部材の前記弁部の外周面と、前記ノズル本体の前記基部の端面に形成された環状突部の内面とで形成されていることが好ましい。 The seal portion is preferably formed by an outer peripheral surface of the valve portion of the slide member and an inner surface of an annular protrusion formed on the end surface of the base portion of the nozzle body.

前記シール部は、前記基部の前記投薬容器の内部を臨む端面に接着されたシート材からなる。 The sealing portion is made of a sheet material adhered to an end face of the base portion facing the inside of the dosing container.

前記スライド部材は、前記シール部に対向する尖鋭端を有し、該尖鋭端により前記シール部を突き破るように構成されている。 The slide member has a sharp end facing the seal portion, and is configured to penetrate the seal portion by the sharp end.

前記スライド部材は、前記シール部を押圧して当該シール部の接着を剥離するように構成されている。 The slide member is configured to press the seal portion to peel off the adhesion of the seal portion.

前記スライド部材の外面に形成された流入孔から、前記スライド部材の内部を通る流路が形成されていることが好ましい。 It is preferable that a flow path passing through the inside of the slide member is formed from the inflow hole formed on the outer surface of the slide member.

前記基部の内面と前記スライド部材の外面との間を通る流路が形成されていることが好ましい。 It is preferable that a flow path passing between the inner surface of the base portion and the outer surface of the slide member is formed.

また、本発明の投薬容器は、入口部と排出部とを有し、前記排出部に前記ノズルが取り付けられているものである。 Further, the dosing container of the present invention has an inlet portion and a discharge portion, and the nozzle is attached to the discharge portion.

本発明によれば、雌コネクタに雄コネクタを装着するだけで、スライド部材が移動して、シール部が解除されるので、簡単な動作で、投薬容器内の医薬品と液体の混合物をスライド部材に沿って円滑に流出することができる。また、雄コネクタを装着するときに雄コネクタによりスライド部材を移動させる構造であるので、雌コネクタと雄コネクタの構造を変更する必要がなく、ISO80369-3のねじ込み式のコネクタを適用することができるという効果を有する。 According to the present invention, simply by attaching the male connector to the female connector, the slide member moves and the seal portion is released, so that the mixture of the drug and the liquid in the dosing container can be used as the slide member with a simple operation. It can flow out smoothly along. Further, since the slide member is moved by the male connector when the male connector is attached, it is not necessary to change the structure of the female connector and the male connector, and the screw-in type connector of ISO80369-3 can be applied. It has the effect of.

本発明のノズルが取り付けられた投薬容器の斜視図。A perspective view of a dosing container to which the nozzle of the present invention is attached. 本発明の第1実施形態に係るノズルと雄コネクタの断面図。Sectional drawing of the nozzle and the male connector which concerns on 1st Embodiment of this invention. 図2のノズルの平面図。The plan view of the nozzle of FIG. 図2のノズルのスライド部材を引き出した状態を示す斜視図。FIG. 2 is a perspective view showing a state in which the slide member of the nozzle of FIG. 2 is pulled out. 図2のノズルのスライド部材を引き出した状態を示す一部破断正面図。A partially broken front view showing a state in which the slide member of the nozzle of FIG. 2 is pulled out. 本発明のノズルが取り付けられた投薬容器により医薬品の懸濁中(a)及びコネクタ接続の状況(b)を示す側面図。The side view which shows the state of suspension (a) and the connector connection (b) of the drug by the dosing container to which the nozzle of this invention is attached. 図2のノズルに雄コネクタを装着した状態を示す断面図。FIG. 2 is a cross-sectional view showing a state in which a male connector is attached to the nozzle of FIG. 第1実施形態の変形例を示す斜視図。The perspective view which shows the modification of 1st Embodiment. 第1実施形態の他の変形例を示す一部破断正面図。The partially broken front view which shows the other modification of 1st Embodiment. 本発明の第2実施形態に係るノズルの断面図。Sectional drawing of the nozzle which concerns on 2nd Embodiment of this invention. 図10のノズルの平面図。Top view of the nozzle of FIG. 図10のノズルに雄コネクタを装着した状態を示す断面図。FIG. 5 is a cross-sectional view showing a state in which a male connector is attached to the nozzle of FIG. 本発明の第3実施形態に係るノズルの断面図。Sectional drawing of the nozzle which concerns on 3rd Embodiment of this invention. 図13のノズルの平面図。The plan view of the nozzle of FIG. 図13のノズルに雄コネクタを装着する途中の状態を示す断面図。FIG. 3 is a cross-sectional view showing a state in which a male connector is being attached to the nozzle of FIG. 図13のノズルに雄コネクタを装着した状態を示す断面図。FIG. 3 is a cross-sectional view showing a state in which a male connector is attached to the nozzle of FIG.

以下、本発明の実施形態を添付図面に従って説明する。 Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings.

<第1実施形態>
図1は、本発明の第1実施形態のノズル10が取り付けられた投薬容器1を示す。投薬容器1は、無色透明、半透明又は有色透明でポリエチレン等の軟質の合成樹脂で形成されている。投薬容器1は、矩形の2枚のシート2a、2bを重ね合わせ、両側の縁部3を互いに接着するとともに、底の縁部4の中央の排出部5にノズル10を挟み、該底の縁部4を接着することにより、内部に医薬品と液体を収容する収容部6が形成されている。シート2aの上縁部7はシート2bの上縁部7より下方に設けられて入口部8となっている。入口部8の内側は溝と突条からなる周知のチャックテープ9が設けられ、収容部6を開閉可能にしている。収容部6の底はノズル10に向かって傾斜している。投薬容器1の底縁部4の両側には吊り孔4a、上縁部7の中央には吊り孔7aが形成されている。
<First Embodiment>
FIG. 1 shows a dosing container 1 to which the nozzle 10 of the first embodiment of the present invention is attached. The dosing container 1 is colorless and transparent, translucent or colored transparent, and is made of a soft synthetic resin such as polyethylene. In the dosing container 1, two rectangular sheets 2a and 2b are overlapped with each other, the edges 3 on both sides are adhered to each other, and the nozzle 10 is sandwiched between the discharge portion 5 in the center of the bottom edge portion 4 and the bottom edge thereof. By adhering the portions 4, a storage portion 6 for accommodating a drug and a liquid is formed inside. The upper edge portion 7 of the sheet 2a is provided below the upper edge portion 7 of the sheet 2b and serves as an inlet portion 8. A well-known chuck tape 9 composed of a groove and a ridge is provided on the inside of the inlet portion 8 so that the accommodating portion 6 can be opened and closed. The bottom of the accommodating portion 6 is inclined toward the nozzle 10. Suspension holes 4a are formed on both sides of the bottom edge portion 4 of the dosing container 1, and suspension holes 7a are formed in the center of the upper edge portion 7.

図2は、第1実施形態のノズル10を示し、このノズル10は、ノズル本体11と、スライド部材12とから構成されている。ノズル本体11及びスライド部材12は、共にポリエチレン等の合成樹脂で形成されている。 FIG. 2 shows the nozzle 10 of the first embodiment, and the nozzle 10 is composed of a nozzle body 11 and a slide member 12. Both the nozzle body 11 and the slide member 12 are made of a synthetic resin such as polyethylene.

ノズル本体11は、投薬容器1の排出部5に取り付けられる基部13と、投薬容器1の外方に突出する雌コネクタ14とが一体に形成されたものである。 The nozzle body 11 is integrally formed with a base 13 attached to the discharge portion 5 of the medication container 1 and a female connector 14 projecting outward from the medication container 1.

ノズル本体11の基部13は、図3に示すように、横断面が菱形で、対向する鈍角の角部が円弧で形成されている。基部13には、雌コネクタ14の内部と連通する貫通孔15が形成されている。基部13は、投薬容器1の収容部6に臨む内端面16を有している。基部13の内端面16には、図4に示すように、貫通孔15と同心の環状突部17が形成されている。環状突部17は、図5に示すように、基端から先端に向かって径が大きくなるように傾斜し、先端には内側に向かって突出する係止部18が形成されている。 As shown in FIG. 3, the base portion 13 of the nozzle body 11 has a rhombic cross section and opposite obtuse-angled corners formed by an arc. The base 13 is formed with a through hole 15 that communicates with the inside of the female connector 14. The base 13 has an inner end surface 16 facing the accommodating portion 6 of the medication container 1. As shown in FIG. 4, an annular protrusion 17 concentric with the through hole 15 is formed on the inner end surface 16 of the base portion 13. As shown in FIG. 5, the annular protrusion 17 is inclined so that the diameter increases from the base end toward the tip end, and a locking portion 18 projecting inward is formed at the tip end.

ノズル本体11の雌コネクタ14は、図2に示すように、基部13の貫通孔に連通する円筒形状を有し、外周面に雄ねじ14aが形成されている。雌コネクタ14には、図1に示すように、経鼻胃管、又は胃瘻や腸瘻のカテーテルに接続されたチューブ(以下、単に「チューブ)という)26の雄コネクタ27がねじ込んで装着される。雄コネクタ27は、図2に示すように、雌コネクタ14に挿入される円筒部27aと、雌コネクタ14の雄ねじ14aに螺合する雌ねじ27bが形成された外筒部27cとからなる。雌コネクタ14と雄コネクタ27は、ISO80369-3に規定された寸法を有する。 As shown in FIG. 2, the female connector 14 of the nozzle body 11 has a cylindrical shape communicating with the through hole of the base 13, and a male screw 14a is formed on the outer peripheral surface. As shown in FIG. 1, a male connector 27 of a tube (hereinafter, simply referred to as “tube”) 26 connected to a nasogastric tube or a catheter for a gastrostomy or an intestinal fistula is screwed and attached to the female connector 14. As shown in FIG. 2, the male connector 27 includes a cylindrical portion 27a inserted into the female connector 14 and an outer cylinder portion 27c formed with a female screw 27b screwed into the male screw 14a of the female connector 14. The female connector 14 and the male connector 27 have the dimensions specified in ISO80369-3.

スライド部材12は、軸部19と、該軸部19の基端に設けられた弁部20とを有している。軸部19は、ノズル本体11の貫通孔15にスライド可能に挿入されている。軸部19は、円筒形で、ノズル本体11の基部13よりも長い長さを有する。このため、軸部19をノズル本体11の貫通孔15に挿入し、弁部20をノズル本体11の基部13の内端面16に当接したときに、軸部19の先端が雌コネクタ14の内部に突出するようになっている。軸部19は、雌コネクタ14の流体ルーメン内径d1より小さく、雄コネクタ27の内筒部27aの内径d2より大きい外径Dを有し、雄コネクタ27の内筒部27aの先端に当接するようになっている。 The slide member 12 has a shaft portion 19 and a valve portion 20 provided at the base end of the shaft portion 19. The shaft portion 19 is slidably inserted into the through hole 15 of the nozzle body 11. The shaft portion 19 is cylindrical and has a length longer than that of the base portion 13 of the nozzle body 11. Therefore, when the shaft portion 19 is inserted into the through hole 15 of the nozzle body 11 and the valve portion 20 comes into contact with the inner end surface 16 of the base portion 13 of the nozzle body 11, the tip of the shaft portion 19 is inside the female connector 14. It is designed to protrude into. The shaft portion 19 has an outer diameter D smaller than the fluid lumen inner diameter d1 of the female connector 14 and larger than the inner diameter d2 of the inner cylinder portion 27a of the male connector 27 so as to abut on the tip of the inner cylinder portion 27a of the male connector 27. It has become.

軸部19の基端側には、2つの流入口22が対向する位置に形成されている。2つの流入口22は、それぞれ長円形状で、軸部19の内部の横断面積以上の開口面積を有する。2つの流入口22の弁部20からの位置は、軸部19をノズル本体11の貫通孔15に挿入し、弁部20をノズル本体11の基部13の内端面16に当接したときに、ノズル本体11の基部13内に潜伏し、雌コネクタ14に雄コネクタ27を装着することにより軸部19が投薬容器1の収容部6側に移動したときに、ノズル本体11の基部13から露出するような位置に形成されている。 Two inflow ports 22 are formed at positions facing each other on the base end side of the shaft portion 19. Each of the two inlets 22 has an oval shape and has an opening area equal to or larger than the cross-sectional area inside the shaft portion 19. The positions of the two inlets 22 from the valve portion 20 are such that when the shaft portion 19 is inserted into the through hole 15 of the nozzle body 11 and the valve portion 20 abuts on the inner end surface 16 of the base portion 13 of the nozzle body 11. It is hidden in the base 13 of the nozzle body 11 and is exposed from the base 13 of the nozzle body 11 when the shaft portion 19 is moved to the accommodating portion 6 side of the medication container 1 by attaching the male connector 27 to the female connector 14. It is formed in such a position.

スライド部材12の弁部20は、円形で、軸部19の基端に軸部19と同心に一体に形成されている。弁部20の下面は、ノズル本体11の基部13の内端面16と接触し、離間するように形成されている。弁部20の外周面21は、図5に示すように、軸部19に向かって先細りになるように傾斜し、ノズル本体11の環状突部17の内面に密着するように形成されている。 The valve portion 20 of the slide member 12 is circular and is formed concentrically with the shaft portion 19 at the base end of the shaft portion 19. The lower surface of the valve portion 20 is formed so as to be in contact with and separated from the inner end surface 16 of the base portion 13 of the nozzle body 11. As shown in FIG. 5, the outer peripheral surface 21 of the valve portion 20 is formed so as to be inclined so as to taper toward the shaft portion 19 and to be in close contact with the inner surface of the annular protrusion 17 of the nozzle body 11.

弁部20の外周面21と、ノズル本体11の基部13の環状突部17は、投薬容器1の収容部6から、ノズル本体11の基部13の内端面16とスライド部材12の弁部20との間を通って、流入口22、軸部19の内部を経て外部に至る流路をシールするシール部23を構成している。シール部23は、環状突部17の上端に形成された係止部18が弁部20の外周縁に係止することでシール状態に維持している。 The outer peripheral surface 21 of the valve portion 20 and the annular protrusion 17 of the base 13 of the nozzle body 11 are from the accommodating portion 6 of the medication container 1 to the inner end surface 16 of the base 13 of the nozzle body 11 and the valve portion 20 of the slide member 12. It constitutes a sealing portion 23 that seals a flow path that passes through the space, passes through the inside of the inflow port 22 and the shaft portion 19, and reaches the outside. The seal portion 23 is maintained in a sealed state by engaging the locking portion 18 formed at the upper end of the annular protrusion 17 with the outer peripheral edge of the valve portion 20.

次に、前記構成のノズル10を備えた投薬容器1を使用して簡易懸濁法により投薬を行う場合における特にノズル10の作用を説明する。 Next, the operation of the nozzle 10 in particular when the dosing is performed by the simple suspension method using the dosing container 1 provided with the nozzle 10 having the above configuration will be described.

投薬容器1の排出部5のノズル10のスライド部材12の弁部20が閉じ、ノズル本体11の係止部18がスライド部材12の弁部20に係止していることを確認してから、投薬容器1のチャックテープ9を開き、入口部8を広げて、患者の投薬に必要なカプセル剤や錠剤等の医薬品と、常温の水または55℃の温湯を入れて、チャックテープ9を閉じる。この状態で、投薬容器1を所定時間放置し、医薬品を崩壊、懸濁させる。必要に応じて、投薬容器1を振ったり、外側から外力を加えて医薬品を崩壊させてもよい。ノズル10は、スライド部材12の弁部20が閉じており、シール部23でシールされているので、投薬容器1の収容部6内の医薬品と温湯の懸濁液が外部に漏れることはない。懸濁中は、図6(a)に示すように、ノズル10を上にして、投薬容器1をノズル10側の吊り孔4aをスタンド24のフック25に掛けて吊るしてもよい。常温の水で懸濁した場合は、人の体温近くまで加温してもよい。 After confirming that the valve portion 20 of the slide member 12 of the nozzle 10 of the discharge portion 5 of the medication container 1 is closed and the locking portion 18 of the nozzle body 11 is locked to the valve portion 20 of the slide member 12. The chuck tape 9 of the medication container 1 is opened, the inlet portion 8 is opened, a drug such as a capsule or a tablet necessary for the patient's medication, water at room temperature or hot water at 55 ° C. is put in, and the chuck tape 9 is closed. In this state, the dosing container 1 is left for a predetermined time to disintegrate and suspend the drug. If necessary, the medication container 1 may be shaken or an external force may be applied from the outside to disintegrate the drug. Since the valve portion 20 of the slide member 12 is closed and the nozzle 10 is sealed by the seal portion 23, the suspension of the drug and the hot water in the accommodating portion 6 of the dosing container 1 does not leak to the outside. During suspension, as shown in FIG. 6A, the dosing container 1 may be hung by hanging the suspension hole 4a on the nozzle 10 side on the hook 25 of the stand 24 with the nozzle 10 facing up. When suspended in water at room temperature, it may be heated to near the human body temperature.

投薬容器1内の医薬品と温湯の懸濁液が体温に近い温度になると、図6(b)に示すように、投薬容器1のノズル10の雌コネクタ14にチューブ26の雄コネクタ27を接続する。このとき、図7に示すように、雄コネクタ27の先端にスライド部材12の軸部19の先端が当接して押し込まれる。 When the suspension of the drug and hot water in the dosing container 1 reaches a temperature close to the body temperature, the male connector 27 of the tube 26 is connected to the female connector 14 of the nozzle 10 of the dosing container 1 as shown in FIG. 6 (b). .. At this time, as shown in FIG. 7, the tip of the shaft portion 19 of the slide member 12 comes into contact with the tip of the male connector 27 and is pushed into the tip.

スライド部材12の軸部19が押し込まれることにより、スライド部材12の弁部20が、ノズル本体11の係止部18から外れてシール状態が解除され、スライド部材12の弁部20がノズル本体11の基部13の内端面16から離間して、弁部20が解放され、スライド部材12の軸部19の流入口22が投薬容器1の収容部6の内側に露出する。 When the shaft portion 19 of the slide member 12 is pushed in, the valve portion 20 of the slide member 12 is disengaged from the locking portion 18 of the nozzle body 11 and the sealed state is released, and the valve portion 20 of the slide member 12 is released from the nozzle body 11. The valve portion 20 is released so as to be separated from the inner end surface 16 of the base portion 13, and the inflow port 22 of the shaft portion 19 of the slide member 12 is exposed to the inside of the accommodating portion 6 of the medication container 1.

これにより、スライド部材12の弁部20と、ノズル本体11の基部13の内端面16との間から、スライド部材12の軸部19の2つの流入口22を経て、軸部19の内部に流路が形成され、この流路を通って投薬容器1の収容部6の懸濁液がチューブ26を介して患者の胃や腸に投与される。スライド部材12の軸部19の先端は、チューブ26の雄コネクタ27の先端に当接しているので、懸濁液の流動中にスライド部材12が戻ることはない。 As a result, the liquid flows from between the valve portion 20 of the slide member 12 and the inner end surface 16 of the base portion 13 of the nozzle body 11 to the inside of the shaft portion 19 via the two inlets 22 of the shaft portion 19 of the slide member 12. A passage is formed, through which the suspension of the container 6 of the dosing container 1 is administered to the patient's stomach or intestine via the tube 26. Since the tip of the shaft portion 19 of the slide member 12 is in contact with the tip of the male connector 27 of the tube 26, the slide member 12 does not return during the flow of the suspension.

懸濁液の投与が終わると、チューブ26の雄コネクタ27を外し、ノズル10のスライド部材12の弁部20を投薬容器1の外側から押さえて、弁部20の外周縁をノズル本体11の係止部18に係止する。これにより、スライド部材12が閉じるので、収容部6に付着又は残留している懸濁液を外部に漏らさずに投薬容器1を廃棄することができる。なお、スライド部材12の弁部20を閉じずに投薬容器1を廃棄してもよい。 When the administration of the suspension is completed, the male connector 27 of the tube 26 is removed, the valve portion 20 of the slide member 12 of the nozzle 10 is pressed from the outside of the medication container 1, and the outer peripheral edge of the valve portion 20 is engaged with the nozzle body 11. Locks to the stop 18. As a result, the slide member 12 is closed, so that the dosing container 1 can be discarded without leaking the suspension adhering to or remaining in the accommodating portion 6 to the outside. The dosing container 1 may be discarded without closing the valve portion 20 of the slide member 12.

前記第1実施形態では、スライド部材12の軸部19は、円筒形であるが、図8に示すように、横断面が十字形の棒状にしてもよい。このため、スライド部材12の弁部20が開くと、スライド部材12の軸部31の溝28が投薬容器1の収容部6の内側に露出する。これにより、スライド部材12の弁部20と、ノズル本体11の基部13の内端面16との間から、スライド部材12の軸部31の溝28を通る流路が形成され、この流路を通って投薬容器1の収容部6の懸濁液がチューブ26を介して患者の胃や腸に投与される。 In the first embodiment, the shaft portion 19 of the slide member 12 has a cylindrical shape, but as shown in FIG. 8, the shaft portion 19 may have a cross-shaped cross section. Therefore, when the valve portion 20 of the slide member 12 is opened, the groove 28 of the shaft portion 31 of the slide member 12 is exposed inside the accommodating portion 6 of the dosing container 1. As a result, a flow path is formed between the valve portion 20 of the slide member 12 and the inner end surface 16 of the base portion 13 of the nozzle body 11 through the groove 28 of the shaft portion 31 of the slide member 12, and passes through this flow path. The suspension of the container 6 of the dosing container 1 is administered to the patient's stomach and intestine via the tube 26.

また、図9に示すように、ノズル本体11の基部13の内端面16に環状溝29aを形成し、スライド部材12の弁部20に環状溝29aと嵌合する環状突起29bを設けて、環状溝29aと環状突起29bの嵌合によりシール部29を構成してもよい。 Further, as shown in FIG. 9, an annular groove 29a is formed on the inner end surface 16 of the base portion 13 of the nozzle body 11, and an annular protrusion 29b that fits with the annular groove 29a is provided on the valve portion 20 of the slide member 12, and is annular. The seal portion 29 may be formed by fitting the groove 29a and the annular protrusion 29b.

<第2実施形態>
図10は、第2実施形態のノズル10Aを示す。このノズル10Aは、シール部の構造と、スライド部材の形状が異なる以外は、前記第1実施形態のノズル10と同様であるので、対応する部分には同一符号を附して説明を省略する。
<Second Embodiment>
FIG. 10 shows the nozzle 10A of the second embodiment. The nozzle 10A is the same as the nozzle 10 of the first embodiment except that the structure of the seal portion and the shape of the slide member are different. Therefore, the same reference numerals are given to the corresponding portions and the description thereof will be omitted.

シール部は、投薬容器1の収容部6を臨む内端面16に、貫通孔15を覆うように接着されたシート材30からなる。シート材30は、投薬容器1のシート2a,2bと同様に、ポリエチレン等の軟質の合成樹脂で形成されている。図11に示すように、シート材30の中心から放射状に周囲より肉厚が薄い弱め線31が形成され、中心に押圧力を受けたときに弱め線31に沿って破断するようになっている。 The sealing portion is made of a sheet material 30 bonded to the inner end surface 16 facing the accommodating portion 6 of the medication container 1 so as to cover the through hole 15. The sheet material 30 is made of a soft synthetic resin such as polyethylene, similarly to the sheets 2a and 2b of the dosage container 1. As shown in FIG. 11, a weakening line 31 whose wall thickness is thinner than the surroundings is formed radially from the center of the sheet material 30, and breaks along the weakening line 31 when a pressing force is applied to the center. ..

スライド部材12は、軸部19の先端にシート材30に対向する円錐状の尖鋭端32を有し、該尖鋭端32によりシート材30を突き破るように構成されている。スライド部材12の軸部19の外周には、スライド部材12が雌コネクタ14から抜け出るのを防止するストッパ33が設けられている。 The slide member 12 has a conical sharp end 32 facing the sheet material 30 at the tip of the shaft portion 19, and is configured to penetrate the sheet material 30 by the sharp end 32. A stopper 33 is provided on the outer periphery of the shaft portion 19 of the slide member 12 to prevent the slide member 12 from coming out of the female connector 14.

投薬容器1のノズル10Aの雌コネクタ14にチューブ26の雄コネクタ27を接続すると、図12に示すように、雄コネクタ27によりスライド部材12の軸部19が押し込まれ、スライド部材12の尖鋭端32が、シート材30を突き破り、弱め線31に沿って破断する。この結果、シート材30のシール状態が解除され、スライド部材12の軸部19の流入口22が投薬容器1の収容部6の内側に露出する。 When the male connector 27 of the tube 26 is connected to the female connector 14 of the nozzle 10A of the medication container 1, the shaft portion 19 of the slide member 12 is pushed by the male connector 27 as shown in FIG. 12, and the sharp end 32 of the slide member 12 is pushed. However, it breaks through the sheet material 30 and breaks along the weakening line 31. As a result, the sealed state of the sheet material 30 is released, and the inflow port 22 of the shaft portion 19 of the slide member 12 is exposed inside the accommodating portion 6 of the dosing container 1.

これにより、投薬容器1の収容部6から、スライド部材12の軸部19の2つの流入口22を経て、軸部19の内部に流路が形成され、この流路を通って投薬容器1の収容部6の懸濁液がチューブ26を介して患者の胃や腸に投与される。 As a result, a flow path is formed from the accommodating portion 6 of the dosing container 1 through the two inlets 22 of the shaft portion 19 of the slide member 12 to the inside of the shaft portion 19, and the dosing container 1 passes through this flow path. The suspension of the container 6 is administered to the patient's stomach or intestine via the tube 26.

<第3実施形態>
図13は、第3実施形態のノズル10Bを示す。このノズル10Bは、シール部の構造と、スライド部材の形状が異なる以外は、前記第1実施形態のノズル10と同様であるので、対応する部分には同一符号を附して説明を省略する。
<Third Embodiment>
FIG. 13 shows the nozzle 10B of the third embodiment. The nozzle 10B is the same as the nozzle 10 of the first embodiment except that the structure of the seal portion and the shape of the slide member are different. Therefore, the same reference numerals are given to the corresponding portions and the description thereof will be omitted.

シール部は、投薬容器1の収容部6を臨む内端面16に、貫通孔15を覆うように接着されたシート材30からなる。シート材30は、投薬容器1のシート2a、2bと同様に、ポリエチレン等の軟質の合成樹脂で形成されている。シート材30の図14にハッチングで示す接着部30aは、中心に押圧力を受けたときに剥離するような接着力で内端面19に接着されている。 The sealing portion is made of a sheet material 30 bonded to the inner end surface 16 facing the accommodating portion 6 of the medication container 1 so as to cover the through hole 15. The sheet material 30 is made of a soft synthetic resin such as polyethylene, similarly to the sheets 2a and 2b of the dosage container 1. The adhesive portion 30a shown by hatching in FIG. 14 of the sheet material 30 is adhered to the inner end surface 19 with an adhesive force that peels off when a pressing force is applied to the center.

スライド部材12は、軸部19の先端がシート材30に接着されている。軸部19の先端をシート材30に接着しなくてもよいが、この場合、第2実施形態のスライド部材と同様に、スライド部材12の軸部19の外周に、スライド部材12が雌コネクタ14から抜け出るのを防止するストッパ33を設けることが好ましい。 The tip of the shaft portion 19 of the slide member 12 is adhered to the sheet material 30. The tip of the shaft portion 19 does not have to be adhered to the sheet material 30, but in this case, the slide member 12 has a female connector 14 on the outer periphery of the shaft portion 19 of the slide member 12, as in the slide member of the second embodiment. It is preferable to provide a stopper 33 for preventing the stopper 33 from coming out of the.

投薬容器1のノズル10Aの雌コネクタ14にチューブ26の雄コネクタ27を接続すると、図15に示すように、雄コネクタ27により、スライド部材12の軸部19が押し込まれ、スライド部材12の先端が、シート材30を押し上げ、やがて、図16に示すように、シート材30の接着部30aが剥離する。この結果、シート材30のシール状態が解除され、スライド部材12の軸部19の流入口22が投薬容器1の収容部6の内側に露出する。 When the male connector 27 of the tube 26 is connected to the female connector 14 of the nozzle 10A of the medication container 1, as shown in FIG. 15, the shaft portion 19 of the slide member 12 is pushed by the male connector 27, and the tip of the slide member 12 is pushed. , The sheet material 30 is pushed up, and eventually, as shown in FIG. 16, the adhesive portion 30a of the sheet material 30 is peeled off. As a result, the sealed state of the sheet material 30 is released, and the inflow port 22 of the shaft portion 19 of the slide member 12 is exposed inside the accommodating portion 6 of the dosing container 1.

これにより、投薬容器1の収容部6から、スライド部材12の軸部19の2つの流入口22を経て、軸部19の内部に流路が形成され、この流路を通って投薬容器1の収容部6の懸濁液がチューブ26を介して患者の胃や腸に投与される。 As a result, a flow path is formed from the accommodating portion 6 of the dosing container 1 through the two inlets 22 of the shaft portion 19 of the slide member 12 to the inside of the shaft portion 19, and the dosing container 1 passes through this flow path. The suspension of the container 6 is administered to the patient's stomach or intestine via the tube 26.

本発明は以上の実施形態に限らず、特許請求の範囲に記載した発明の範囲内で種々変更することができる。 The present invention is not limited to the above embodiments, and various modifications can be made within the scope of the invention described in the claims.

1…投薬容器
5…排出部
8…入口部
10,10A,10B…ノズル
11…ノズル本体
12…スライド部材
13…基部
14…雌コネクタ
15…貫通孔
17…環状突部
19…軸部
20…弁部
21…外周面
23…シール部
26…チューブ
27…雄コネクタ
30…シート材(シール部)
31…弱め線
32…尖鋭端



1 ... Medication container 5 ... Discharge part 8 ... Inlet part 10, 10A, 10B ... Nozzle 11 ... Nozzle body 12 ... Slide member 13 ... Base 14 ... Female connector 15 ... Through hole 17 ... Circular protrusion 19 ... Shaft part 20 ... Valve Part 21 ... Outer surface 23 ... Seal part 26 ... Tube 27 ... Male connector 30 ... Sheet material (seal part)
31 ... Weak line 32 ... Sharp edge



Claims (3)

入口部と排出部とを有する投薬容器の前記排出部に取り付けられる投薬容器用ノズルにおいて、
前記投薬容器の内部と連通する貫通孔を有し、前記排出部に取り付けられる基部と、
前記基部に一体に形成され、前記基部の貫通孔に連通する円筒形状を有し、外周面に雄ねじが形成された雌コネクタとを備え、
前記投薬容器の内部と前記基部の前記貫通孔との間にシール部が設けられ、
前記シール部と前記雌コネクタとの間にスライド部材が設けられ、
前記雌コネクタに挿入される円筒部と、前記雄ねじに螺合する雌ねじが形成された外筒部とからなる雄コネクタが、前記雌コネクタに装着されると、前記スライド部材が移動して、前記シール部を解除するように構成され、
前記スライド部材は、円筒形の軸部と、前記基部に接離可能な弁部を有し、前記軸部に流入口が形成され、
前記シール部は、前記弁部の外周面と前記基部に形成された環状突部とで構成され、
前記環状突部の上端に形成された係止部が前記弁部の外周縁に係止することでシール状態に維持するように構成され、
前記スライド部材は、前記弁部を前記基部から離間して前記シール部を開放するように構成されている投薬容器用ノズル。
In a nozzle for a medication container attached to the discharge portion of a medication container having an inlet portion and a discharge portion,
A base that has a through hole that communicates with the inside of the dosing container and is attached to the discharge portion.
It is provided with a female connector integrally formed with the base portion, having a cylindrical shape communicating with a through hole of the base portion, and having a male screw formed on the outer peripheral surface.
A seal is provided between the inside of the dosing container and the through hole at the base.
A slide member is provided between the seal portion and the female connector.
When a male connector including a cylindrical portion inserted into the female connector and an outer cylinder portion having a female screw screwed to the male screw is attached to the female connector, the slide member moves and the slide member moves. It is configured to release the seal and
The slide member has a cylindrical shaft portion and a valve portion that can be brought into contact with the base portion, and an inflow port is formed in the shaft portion.
The seal portion is composed of an outer peripheral surface of the valve portion and an annular protrusion formed on the base portion.
The locking portion formed at the upper end of the annular protrusion is configured to be locked to the outer peripheral edge of the valve portion to maintain the sealed state.
The slide member is a nozzle for a dosing container configured to open the seal portion by separating the valve portion from the base portion.
入口部と排出部とを有する投薬容器の前記排出部に取り付けられる投薬容器用ノズルにおいて、
前記投薬容器の内部と連通する貫通孔を有し、前記排出部に取り付けられる基部と、
前記基部に一体に形成され、前記基部の貫通孔に連通する円筒形状を有し、外周面に雄ねじが形成された雌コネクタとを備え、
前記投薬容器の内部と前記基部の前記貫通孔との間にシール部が設けられ、
前記シール部と前記雌コネクタとの間にスライド部材が設けられ、
前記雌コネクタに挿入される円筒部と、前記雄ねじに螺合する雌ねじが形成された外筒部とからなる雄コネクタが、前記雌コネクタに装着されると、前記スライド部材が移動して、前記シール部を解除するように構成され、
前記スライド部材は、円筒形の軸部を有し、前記軸部に流入口が形成され、
前記シール部は、前記基部の前記投薬容器の内部を臨む端面に接着されたシート材からなり、
前記スライド部材は、前記シート材を押圧して当該シート材の接着を剥離するように構成されている投薬容器用ノズル。
In a nozzle for a medication container attached to the discharge portion of a medication container having an inlet portion and a discharge portion,
A base that has a through hole that communicates with the inside of the dosing container and is attached to the discharge portion.
It is provided with a female connector integrally formed with the base portion, having a cylindrical shape communicating with a through hole of the base portion, and having a male screw formed on the outer peripheral surface.
A seal is provided between the inside of the dosing container and the through hole at the base.
A slide member is provided between the seal portion and the female connector.
When a male connector including a cylindrical portion inserted into the female connector and an outer cylinder portion having a female screw screwed to the male screw is attached to the female connector, the slide member moves and the slide member moves. It is configured to release the seal and
The slide member has a cylindrical shaft portion, and an inflow port is formed in the shaft portion.
The sealing portion is made of a sheet material adhered to an end face of the base portion facing the inside of the dosage container.
The slide member is a nozzle for a dosing container configured to press the sheet material to peel off the adhesion of the sheet material .
入口部と排出部とを有し、前記排出部に請求項1又は2に記載のノズルが取り付けられていることを特徴とする投薬容器。
A dosing container having an inlet portion and a discharge portion, wherein the nozzle according to claim 1 or 2 is attached to the discharge portion.
JP2018099920A 2018-05-24 2018-05-24 Dosing container nozzle and dosing container Active JP7043136B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018099920A JP7043136B2 (en) 2018-05-24 2018-05-24 Dosing container nozzle and dosing container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018099920A JP7043136B2 (en) 2018-05-24 2018-05-24 Dosing container nozzle and dosing container

Publications (2)

Publication Number Publication Date
JP2019201996A JP2019201996A (en) 2019-11-28
JP7043136B2 true JP7043136B2 (en) 2022-03-29

Family

ID=68725522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018099920A Active JP7043136B2 (en) 2018-05-24 2018-05-24 Dosing container nozzle and dosing container

Country Status (1)

Country Link
JP (1) JP7043136B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102596907B1 (en) * 2023-06-15 2023-11-01 석지원 One-touch all-in-one combined medical humidifier

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005520635A (en) 2002-03-26 2005-07-14 カルメル プハルマ アクチボラゲット Fluid transfer assembly
JP2016510247A (en) 2013-02-13 2016-04-07 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Bulkhead actuator with insertion depth limiter and compression compensator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188628A (en) * 1990-11-06 1993-02-23 Sandoz Ltd. Closure device for enteral fluid containers
US5533983A (en) * 1993-11-26 1996-07-09 Haining; Michael L. Valved medical connector

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005520635A (en) 2002-03-26 2005-07-14 カルメル プハルマ アクチボラゲット Fluid transfer assembly
JP2016510247A (en) 2013-02-13 2016-04-07 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Bulkhead actuator with insertion depth limiter and compression compensator

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102596907B1 (en) * 2023-06-15 2023-11-01 석지원 One-touch all-in-one combined medical humidifier
WO2024258021A1 (en) * 2023-06-15 2024-12-19 주식회사 세인메디 One-touch integrated-coupling-type medical humidifier

Also Published As

Publication number Publication date
JP2019201996A (en) 2019-11-28

Similar Documents

Publication Publication Date Title
US10933202B1 (en) Indicator member of low strength resistance for a tamper evident closure
AU673058B2 (en) Closure for medication container
US4614515A (en) Drug delivery system
US3394831A (en) Apparatus for storing and handling parenteral liquids and method for opening same
JP2958345B2 (en) Container stopper
JP4171649B2 (en) Beverage pack adapter and beverage supply apparatus
BR112014008551B1 (en) VALVE SET FOR USE WITH CONTAINER OF LIQUID AND MEDICINE BOTTLE AND LIQUID MEDICINE TRANSFER UNIT
JP6310855B2 (en) package
US5348060A (en) Drug vessel
EP3897509B1 (en) Enteral nutrition container cap and methods of making and using the cap
SG192151A1 (en) Medical administering set
CN104367476B (en) Cap and nutritional supplement container using same
AU679509B2 (en) New urea derivates, their preparation and their use
US20230248957A1 (en) System comprising a cap for a medical fluid container and an attachment part, medical fluid container, and method for producing a fluid container
JP2015513418A (en) Vials with free float valves for sterile pharmaceuticals
KR20180008501A (en) A sealing device capable of collecting the composition, a packing assembly with such a sealing device, collection and packing methods
JP7043136B2 (en) Dosing container nozzle and dosing container
CN102573754B (en) Connector set for medical container
JP7077016B2 (en) cap
JP4405446B2 (en) Spout and pouch for preventing misconnection
JP6836396B2 (en) Nozzle for medication container and medication container
JP7639599B2 (en) adapter
JP3954372B2 (en) Beverage pack adapter and beverage supply apparatus
JPH0288664U (en)
JP6345391B2 (en) Male connector

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20190529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190530

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210512

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211214

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220208

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220315

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220315

R150 Certificate of patent or registration of utility model

Ref document number: 7043136

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250